Choriogonadotropin Alfa Injection Articles
Serono beats expectations with 3rd-qtr 2003 net income up 48%
3 November 2003
Serono makes strong start to 2001
2 May 2001
EU approves highest dose of Serono's Rebif
5 February 2001
Rebif pushes Serono sales up 16.2%
23 January 2001
Stock Commentary Europe
12 October 2000
Stock Commentary Europe
5 October 2000
FDA grants first OK for Serono's Ovidrel
3 October 2000
First EMEA Approval Is For Serono's Gonal-F
30 October 1995
Showing 1-11 of 11 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
